510(k) Report

FDA applicant

Ceribell, Inc.

Sunnyvale, CA16 decisions2017–20260 recalls

FDA records 16 decisions for Ceribell, Inc. (Sunnyvale, CA) from 2017 to 2026: 16 510(k) clearances. Most are in product codes GXY (Electrode, Cutaneous) and OMB (Automatic Event Detection Software For…). Since 2016 its 510(k)s took a median of 130 days from receipt to decision, against 138 for FDA’s reviews in the same codes and years. Its devices cite 24 predicates, 14 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, neurology panel, where it files most

How often FDA has decided Ceribell, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

4in 2025

2017: 22019: 12021: 12023: 32025: 42026 (partial year): 5
2017high 5 (2026) · low 0 (2018)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2017.

FIG. 1 — Ceribell, Inc. by year, 2017–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Ceribell, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report